RAPT Therapeutics $143.7 million follow-on offering
We advised the joint book-running managers on the SEC-registered equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
CARsgen Therapeutics HK$3.1 billion IPO
We advised CARsgen Therapeutics on its IPO and HKEX listing
Apria $139.7 million stock offering
We advised the underwriters on the SEC-registered equity offering
Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
Oak Street Health $747.2 million secondary offering
We advised the joint book-running managers on the equity offering
Esco Lifesciences $200 million Series A financing
We are advising Esco Lifesciences on its Series A financing
Fresenius Medical Care $1.5 billion notes offering
We advised the initial purchasers on the Rule 144A / Regulation S notes offering
Accuray private exchange offers
We advised Accuray on its exchange of convertible senior notes
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing